Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Narrative medicine in patients with cancer during intravenous antiblastic therapy: a qualitative study.
Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sleep Quality in Spanish Adult Women: Associations with Sociodemographic Variables and Pre-Sleep Habits.Healthcare (Basel, Switzerland) · 2026Article
- The healing promise of narrative medicine in cancer care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with cancer during antineoplastic infusion therapy live an existential period characterized by experiences of profound psychological, physical, social, and spiritual changes. PURPOSE: To explore the patients' experiences during antineoplastic therapy using narrative medicine.
methodsA qualitative descriptive study, utilizing content analysis, was embedded within a randomized controlled three-arm trial. The study focused on analyzing their writings expressed through narrative medicine. The narrative medicine intervention was administered immediately after the start of antineoplastic therapy. While seated in outpatient chairs, and after the infusion began, a trained nurse provided participants with a pen and notepad, explaining that they could use the next 30 min to freely write about their subjective experiences during the infusion of antineoplastic therapy.
resultsData from twenty-four interviews reached saturation. Content analysis identified five main categories and twelve subcategories: cognitive processes (positive thoughts, negative thoughts, memory, attention, imagination, learning); emotive processes (primary negative emotions, secondary negative emotions, primary positive emotions, secondary positive emotions); behavioral processes (positive behaviors); social processes (social relationships with healthcare professionals, social relationships with family members, social relationships with caregivers); and perceptual processes (adverse effects of antineoplastic therapy).
conclusionsOur finding revealed the complex, multidimensional experiences of patients undergoing antineoplastic therapy. Narrative medicine facilitated a profound, multidimensional exploration of their experience of receiving antineoplastic therapy, addressing psychological, physical, social, and spiritual aspects.
Indexed as
Identifiers
40447965What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.